The brand name for clozapine is Clozaril [1]. Other brand names for clozapine include Fazaclo and Versacloz [2].
Why is Clozapine Prescribed?
Clozapine is a prescription medication used to treat schizophrenia in patients who have not responded to or cannot tolerate other treatments [1][3]. It is also used to reduce the risk of suicidal behavior in patients with schizophrenia or schizoaffective disorder [1].
How Does Clozapine Work?
The exact mechanism by which clozapine works is not fully understood, but it is believed to affect dopamine and serotonin receptors in the brain [3]. By influencing these neurotransmitters, clozapine can help manage symptoms of psychosis, such as hallucinations and delusions, and reduce impulsive or suicidal behavior [1][3].
What are the Risks Associated with Clozapine?
Clozapine carries significant risks, most notably agranulocytosis, a dangerous drop in white blood cells that can increase the risk of life-threatening infections [1][3]. Because of this risk, patients taking clozapine must have their blood counts monitored regularly [1][3]. Other serious side effects can include seizures, myocarditis (inflammation of the heart muscle), cardiomyopathy (heart muscle disease), and orthostatic hypotension (a sudden drop in blood pressure upon standing) [1][3]. Due to these risks, clozapine is typically reserved for individuals who have not found relief with other antipsychotic medications [1].
Are There Other Medications Like Clozapine?
While clozapine is unique in its efficacy for treatment-resistant schizophrenia, other antipsychotic medications are available. These include second-generation antipsychotics such as risperidone, olanzapine, quetiapine, and aripiprazole, which have different efficacy and side effect profiles [4].
When Does Clozapine Patent Protection End?
Information regarding specific patent expiry dates for clozapine brand names can be found on DrugPatentWatch.com [5]. Patent timelines are crucial for understanding when generic versions of a medication may become available, potentially impacting pricing and accessibility [5].